Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, March 31, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
-
Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 global Phase 3 registrational trial in post-abiraterone mCRPC, with initiation expected in 1H 2026 At...
-
Inhibitor Therapeutics (OTCQB: INTI) updates itraconazole PK study, highlights amorphous formulation and planned global patent filing.
-
Minneapolis, MN, March 31, 2026 (GLOBE NEWSWIRE) -- As tax filings are prepared and graduation season approaches, many families are taking a closer look at household finances, including health...
-
Indianapolis, INDIANA, March 31, 2026 (GLOBE NEWSWIRE) -- Indiana Rehabs has released its "State of Addiction in Indiana: Annual Report," revealing a remarkable 18% decline in overdose deaths in...
-
AMI is pleased to announce the world broadcast premiere of the original documentary The Last Days of April, Friday, Aug. 7, at 10 p.m. Eastern on AMI-tv.
-
Landmark regulatory milestone makes the River stent available for adults with severe IIH – a debilitating, historically undertreated condition – who have failed medical therapy Serenity Medical...
-
Stage4Hope has announced a $2.5 million multi-year research commitment to Memorial Sloan Kettering Cancer Center (MSK) to support cancer research.
-
AUSTIN, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- As Austin continues to emerge as one of the nation’s most active and athletic cities, Spinal Rehab & Sports Medicine is making headlines for its...
-
Axiom Medical hosted its annual client summit, bringing workplace health, safety, and risk leaders together to share best practices and honor clients.